AMA Issues CPT Code for bioAffinity Technologies' CyPath® Lung Test for Early-Stage Lung Cancer | Business
SAN ANTONIO, Texas--(BUSINESS WIRE)--Jul 12, 2023--
Stay updated with breaking news from Affinity Technologies Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SAN ANTONIO, Texas--(BUSINESS WIRE)--Jul 12, 2023--
BioAffinity Technologies, Inc. , a biotechnology company addressing the need for noninvasive detection of early-stage lung cancer, today announced that the American Medical Association has released...
SAN ANTONIO, Texas--(BUSINESS WIRE)--Jul 12, 2023--
By technology, the LDCT segment will account maximum share in lung cancer screening market during 2022-2030. The lung cancer screening industry majorly...
BioAffinity Technologies, Inc. (NASDAQ:BIAFW – Get Rating) was the recipient of a large increase in short interest in May. As of May 31st, there was short interest totalling 6,300 shares, an increase of 6.8% from the May 15th total of 5,900 shares. Based on an average daily trading volume, of 2,900 shares, the days-to-cover ratio […]